Sinocelltech Group Limited (SHA:688520)

China flag China · Delayed Price · Currency is CNY
51.99
+0.16 (0.31%)
Oct 24, 2025, 3:00 PM CST
0.31%
Market Cap23.15B
Revenue (ttm)2.18B
Net Income (ttm)-47.53M
Shares Out445.34M
EPS (ttm)-0.12
PE Ration/a
Forward PE96.28
Dividendn/a
Ex-Dividend Daten/a
Volume1,759,167
Average Volume3,150,081
Open52.05
Previous Close51.83
Day's Range51.59 - 52.68
52-Week Range33.50 - 89.04
Beta0.77
RSI33.28
Earnings DateOct 31, 2025

About Sinocelltech Group

Sinocelltech Group Limited, a biotech company, engages in the research and development, and industrialization of recombinant proteins, monoclonal antibodies, and innovative vaccines in China. The company offers Anpingxi an antibody drug and anti-tumor product; Anjiayin for the treatment of the rare disease hemophilia A; coronavirus 2-valent, a trimer protein vaccine; and mutant strain recombinant protein vaccines SCTV01C and SCTV01E. Its pipeline products include SCT630 used for the treatment of autoimmune diseases; SCT510 for the treatment of ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 2,277
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688520
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.